Shanghai Pharmaceuticals (China) Today
| 601607 Stock | 21.30 0.45 2.07% |
Performance9 of 100
| Odds Of DistressLess than 1
|
Shanghai Pharmaceuticals is trading at 21.30 as of the 2nd of December 2024, a 2.07 percent decrease since the beginning of the trading day. The stock's open price was 21.75. Shanghai Pharmaceuticals has a very small chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Shanghai Pharmaceuticals Holding are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 2nd of December 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 8th of October 1993 | Category Healthcare | Classification Health Care |
Shanghai Pharmaceuticals is entity of China. It is traded as Stock on SHG exchange. The company has 2.79 B outstanding shares. More on Shanghai Pharmaceuticals Holding
Moving together with Shanghai Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shanghai Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shanghai Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shanghai Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Shanghai Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Shanghai Pharmaceuticals' managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| Executive Chairman | Qiuhua Yang | ||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Care, Health Care Providers & Services, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
| Excise Tax Activities | Animal TestingCatholic | ||||
Shanghai Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Shanghai Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsShanghai Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shanghai Pharmaceuticals' financial leverage. It provides some insight into what part of Shanghai Pharmaceuticals' total assets is financed by creditors.
| |||||
Shanghai Pharmaceuticals Holding (601607) is traded on Shanghai Stock Exchange in China and employs 48,164 people. Shanghai Pharmaceuticals is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 70.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shanghai Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Shanghai Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shanghai Pharmaceuticals operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 2.79 B outstanding shares.
Shanghai Pharmaceuticals generates positive cash flow from operations, but has no cash available
Check Shanghai Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationShanghai Pharmaceuticals shows a total of 2.79 Billion outstanding shares. Shanghai Pharmaceuticals has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.61 % of Shanghai Pharmaceuticals outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shanghai Ownership Details
Shanghai Pharmaceuticals Risk Profiles
Although Shanghai Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Shanghai Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.52 | |||
| Semi Deviation | 1.89 | |||
| Standard Deviation | 2.07 | |||
| Variance | 4.28 |
Shanghai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shanghai Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Shanghai Pharmaceuticals Corporate Directors
Other Information on Investing in Shanghai Stock
Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.